US FDA orders boxed warning for all glitazones

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2007年 / 1165卷 / 1期

关键词：

Heart Failure; Rosiglitazone; Pioglitazone; Thiazolidinedione; Actos;

D O I：

10.2165/00128415-200711650-00006

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[11] FDA requires boxed warning for all immediate-release opioid products
Thompson, Cheryl A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (09) : E114 - E115
[12] Boxed warning for lamotrigine in US
Reactions Weekly, 1997, 647 (1) : 2 - 2
[13] FDA boxed warning of anaphylaxis risk with Xolair
Reactions Weekly, 2007, 1159 (1) : 2 - 2
[14] Depot medoxyprogesterone: impact of FDA boxed warning
Reactions Weekly, 2017, 1655 (1) : 8 - 8
[15] FDA approves prasugrel with a boxed warning for haemorrhage
Reactions Weekly, 2009, 1261 (1) : 3 - 3
[16] Effect of FDA boxed warning on fluoroquinolone stewardship
Reactions Weekly, 2020, 1805 (1) : 8 - 8
[17] FDA: boxed warning removed for varenicline, bupropion
Reactions Weekly, 2017, 1633 (1) : 5 - 5
[18] FDA Boxed Warning for Botulinum Toxin Products
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (06) : 595 - 596
[19] Salmeterol: boxed warning added in US
Reactions Weekly, 2003, 965 (1) : 2 - 2
[20] New Boxed Warning for Nimotop in the US
Reactions Weekly, 2006, 1087 (1) : 3 - 3

← 1 2 3 4 5 →